Research Topics
Genomes and Genes | Carlos Rodriguez-GalindoSummaryAffiliation: St. Jude Children's Research Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Clinical use of topoisomerase I inhibitors in anticancer treatmentC Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Med Pediatr Oncol 35:385-402. 2000..These studies have shown promising results, and have placed topotecan and irinotecan in the first line treatment for some malignancies. However, studies to better determine the optimal schedules and sequence of combinations are needed...
Treatment of metastatic retinoblastomaCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Ophthalmology 110:1237-40. 2003..The risk for death in patients with retinoblastoma is increased in those who present with metastatic disease, and the role of intensive chemotherapy and autologous hematopoietic stem cell rescue in these patients remains unclear...
Clofarabine in refractory Langerhans cell histiocytosisCarlos Rodriguez-Galindo
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Pediatr Blood Cancer 51:703-6. 2008..In this report we describe significant single agent activity of clofarabine in disseminated LCH refractory to salvage regimens, including cladribine...
Prognostic factors for local and distant control in Ewing sarcoma family of tumorsC Rodriguez-Galindo
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Ann Oncol 19:814-20. 2008..The individual contributions of each treatment component cannot be analyzed separately; improvements in local and systemic control can influence each other...
Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000)Carlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, and Department of Pediatrics, University of Tennessee, Memphis, USA
Cancer 100:1928-35. 2004..Despite improvements in therapy for osteosarcoma, approximately 4-10% of patients experience a local recurrence and have a poor prognosis...
Pharmacological management of Ewing sarcoma family of tumoursCarlos Rodriguez-Galindo
St Jude Children s Research Hospital, Department of Hematology Oncology, 332 N Lauderdale, Memphis, TN 38105, USA
Expert Opin Pharmacother 5:1257-70. 2004..The benefit of this approach is unclear and HSCT must therefore be considered investigational. New strategies, such as the use of immunotherapy, biological modifiers and novel classes of chemotherapeutic agents must be explored...
Treatment of retinoblastoma: current status and future perspectivesCarlos Rodriguez-Galindo
Carlos Rodriguez Galindo, MD Department of Oncology, St Jude Children s Research Hospital, 332 N Lauderdale, Memphis, TN 38105, USA
Curr Treat Options Neurol 9:294-307. 2007....
Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinomaCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 103:850-7. 2005..Chemotherapy may help to decrease the radiotherapy dose and limit the side effects of local therapies. However, little is known regarding the chemosensitivity of NPC tumors in pediatric patients...
Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumorsCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2795, USA
Cancer Chemother Pharmacol 57:15-24. 2006..Combining both agents may increase the amount of camptothecin delivered to the tumor, without additive toxicity...
Biology, clinical characteristics, and management of adrenocortical tumors in childrenCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, 332 N Lauderdale, Memphis, TN 38105 2794, USA
Pediatr Blood Cancer 45:265-73. 2005..Multi-institutional and prospective studies are necessary to further our understanding of the pathogenesis and to improve outcomes...
Retinoblastoma: one world, one visionCarlos Rodriguez-Galindo
Department of Oncology, St Jude Children s Research Hospital, 332 N Lauderdale, Memphis, TN 38105, USA
Pediatrics 122:e763-70. 2008....
Treatment of intraocular retinoblastoma with vincristine and carboplatinCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA
J Clin Oncol 21:2019-25. 2003..To evaluate the efficacy of chemoreduction using vincristine and carboplatin in preventing or delaying external-beam radiotherapy (EBRT) or enucleation in patients with intraocular retinoblastoma...
Treatment of Ewing sarcoma family of tumors: current status and outlook for the futureCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Med Pediatr Oncol 40:276-87. 2003..Our current understanding in the biology and treatment of ESFT suggests that a more rational approach to the development of risk-adapted therapy should be undertaken...
Neonatal alveolar rhabdomyosarcoma with skin and brain metastasesC Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Cancer 92:1613-20. 2001..However, because RMS rarely occurs during the neonatal period, little is known about neonatal RMS...
Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosineCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Am J Hematol 69:179-84. 2002..2-CdA needs to be considered for the treatment of recurrent LCH. However, its incorporation into front-line treatment of patients with multi-system LCH needs further study...
Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposideCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
J Pediatr Hematol Oncol 24:250-5. 2002..By identifying new chemotherapeutic strategies, the outcome of these patients can be improved and the toxicity of treatment regimens decreased...
Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999Carlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 94:561-9. 2002..Despite improved therapies, 30-40% of patients with Ewing tumors (ET) experience recurrence and have a poor prognosis. The authors analyzed factors prognostic of survival in patients with recurrent ET...
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factorsMatthew J Krasin
Department of Radiological Sciences, Division of Radiation Oncology, St Jude Children s Research Hospital, 332 North Lauderdale, Memphis, TN 38105 2794, USA
Int J Radiat Oncol Biol Phys 60:830-8. 2004..To assess the effect of radiation dose on local tumor control of the Ewing sarcoma family of tumors in 79 patients with localized disease treated at a single institution...
Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factorsMatthew J Krasin
Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 104:367-73. 2005....
Metastatic osteosarcomaNajat C Daw
Department of Hematology Oncology, St Jude Children s Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee 38105 2794, USA
Cancer 106:403-12. 2006..The initial study (OS-86) used ifosfamide, cisplatin, doxorubicin, and high-dose methotrexate, and the subsequent study (OS-91) used the same agents at similar doses, but carboplatin was substituted for cisplatin...
Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicityIbrahim Qaddoumi
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Cancer 118:5663-70. 2012..New, effective chemotherapeutic agents are needed for intraocular retinoblastoma...
Carboplatin-associated ototoxicity in children with retinoblastomaIbrahim Qaddoumi
St Jude Children s Research Hospital, Memphis, TN 38105 3678, USA
J Clin Oncol 30:1034-41. 2012..We retrospectively assessed the incidence of ototoxicity and its risk factors in children with retinoblastoma who were treated with carboplatin...
Socioeconomic impact of modern multidisciplinary management of retinoblastomaMatthew W Wilson
Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Pediatrics 118:e331-6. 2006..Our objective for this study was to examine the impact of the modern management of intraocular retinoblastoma on the patient and the family...
World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working GroupGuillermo L Chantada
Hospital JP Garrahan, Buenos Aires, Argentina and International Outreach Program, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Pediatr Blood Cancer 50:692-4. 2008..Internet meetings are a valuable mechanism for enabling participation from under-resourced countries in the development of cooperative studies...
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcomaKristine R Crews
Department of Pharmaceutical Sciences, St Judes Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 100:1724-33. 2004..The authors evaluated the impact of factors such as age and prior nephrotoxic agents on MTX pharmacokinetics in children and young adults with osteosarcoma and examined whether MTX pharmacokinetic parameters were associated with outcome...
Clinical field testing of an enhanced-activity intervention in hospitalized children with cancerPamela S Hinds
Division of Nursing Research, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
J Pain Symptom Manage 33:686-97. 2007..Our findings identify design and statistical considerations for a future effectiveness study of the EPA intervention in hospitalized pediatric oncology patients...
Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumorsWayne L Furman
Department of Oncology, St Jude Children s Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105 3678, USA
J Clin Oncol 27:4599-604. 2009..To assess the effect of gefitinib on the pharmacokinetics of IV irinotecan and on the bioavailability of a single oral dose of irinotecan...
Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastomaMatthew W Wilson
Department of Ophthalmology, University of Tennessee Health Science Center, 930 Madison Avenue, Memphis, TN 38163, USA
Am J Ophthalmol 140:397-406. 2005..To evaluate vincristine and carboplatin with intensive focal treatments in the management of intraocular retinoblastoma...
Ocular preservation after 36 Gy external beam radiation therapy for retinoblastomaThomas E Merchant
Department of Radiation Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
J Pediatr Hematol Oncol 24:246-9. 2002..The purpose of this study was to document the ocular preservation rate after 36 Gy external beam radiation therapy (EBRT) for retinoblastoma...
Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcomaMatthew J Krasin
Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Int J Radiat Oncol Biol Phys 76:874-8. 2010..To demonstrate the safety and efficacy of limited margin radiotherapy in the local control of pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft tissue sarcoma (NRSTS)...
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumorsWayne L Furman
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794l, USA
J Clin Oncol 24:563-70. 2006....
PET/CT for staging and follow-up of pediatric nasopharyngeal carcinomaDaniel K L Cheuk
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 3678, USA
Eur J Nucl Med Mol Imaging 39:1097-106. 2012..In this investigation, we studied the utility of FDG PET/CT in children with NPC...
Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumorsLisa M McGregor
Department of Oncology, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Pediatr Blood Cancer 58:372-9. 2012..Administration of an oral cephalosporin allowed advancement of the dosage of oral irinotecan. This study investigates whether administration of an oral cephalosporin increases the maximum tolerated dose (MTD) of intravenous irinotecan...
Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)--part IIScott C Howard
International Outreach Program and Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pediatr Blood Cancer 48:486-90. 2007..Despite the use of all-trans-retinoic acid during induction for acute promyelocytic leukemia, the incidence of fatal hemorrhage remains unacceptably high...
Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studiesCarlos Rodriguez-Galindo
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 110:375-84. 2007..As new treatments are developed, a critical review of data from past treatment eras is needed to identify clinically relevant risk groups...
Successful treatment of early detected trilateral retinoblastoma using standard infant brain tumor therapyKaren D Wright
Department of Oncology, Division of Neuro Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 3678, USA
Pediatr Blood Cancer 55:570-2. 2010..Early diagnosis of trilateral retinoblastoma may facilitate the use of less intensive therapeutic approaches and result in excellent outcomes in these patients...
The effect of cancer therapies on pediatric anophthalmic socketsYevgeniy Shildkrot
Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
Ophthalmology 118:2480-6. 2011..To determine the impact of chemotherapy or external beam radiotherapy (EBRT) on pediatric anophthalmic sockets...
Episcleral plaque brachytherapy for retinoblastomaThomas E Merchant
Division of Radiation Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Pediatr Blood Cancer 43:134-9. 2004..The purpose of this study was to report our experience using episcleral plaque brachytherapy (EPBRT) to treat retinoblastoma and to demonstrate its applicability in multimodality treatment...
Transfer of complex frontline anticancer therapy to a developing country: the St. Jude osteosarcoma experience in ChileGaston K Rivera
International Outreach Program, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Pediatr Blood Cancer 50:1143-6. 2008..Jude Children's Research Hospital (sponsor) and Calvo Mackenna Hospital (CMH, partner), a public pediatric hospital and national center for the treatment of bone tumors in Santiago, Chile...
Retrospective study of the surgical management and outcome of nonrhabdomyosarcoma soft tissue sarcomas of the groin and axilla in childrenGideon Karplus
Department of Surgery, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Pediatr Surg 44:1972-6. 2009..The incidence of pediatric nonrhabdomyosarcoma soft tissue sarcomas (NRSTSs) of the groin and axilla is unknown, and the optimal surgical approach to these patients is unclear...
Functional neuroimaging to characterize visual system development in children with retinoblastomaScott M Barb
Department of Radiological Sciences, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105 2794, USA
Invest Ophthalmol Vis Sci 52:2619-26. 2011..To use functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) to investigate visual system development in children being treated for retinoblastoma...
Retinoblastoma metastatic to the ovary in a patient with Waardenburg syndromeDarius M Moshfeghi
Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
Am J Ophthalmol 133:716-8. 2002..She died within 2 days of admission. CONCLUSION: We believe that this is the first description of a patient with retinoblastoma and Waardenburg syndrome and of an ovarian metastasis from retinoblastoma...
Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatmentsJulia Balaguer
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pediatr Blood Cancer 52:351-6. 2009..The impact of chemotherapy, focal therapies, radiation and co-existing ocular morbidities on histology of eyes with retinoblastoma enucleated following chemoreduction is not well known...
Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?Matthew W Wilson
Department of Ophthalmology Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
Ophthalmology 114:2077-82. 2007..To report the incidence of new tumor formation in hereditary retinoblastoma patients treated with primary systemic chemotherapy...
A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastomaMatthew W Wilson
Hamilton Eye Institute, Memphis, TN 38163, USA
Br J Ophthalmol 95:553-8. 2011..To correlate the clinical and histopathological findings of eyes primarily enucleated for advanced intraocular retinoblastoma...
Coexpression of normally incompatible developmental pathways in retinoblastoma genesisJustina McEvoy
Department of Developmental Neurobiology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Cancer Cell 20:260-75. 2011..Furthermore, neurotransmitter receptors, transporters, and biosynthetic enzymes are expressed in human retinoblastoma, and targeted disruption of these pathways reduces retinoblastoma growth in vivo and in vitro...
Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumorsMatthew J Krasin
Division of Radiation Oncology, Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Pediatr Blood Cancer 43:229-36. 2004..Local failure rates for patients who received combined surgery and RT were reviewed to determine outcome and prognostic factors...
Second cancers in patients with the Ewing sarcoma family of tumoursFariba Navid
Department of Oncology, St Jude Children s Research Hospital, 332 N Lauderdale Street, Memphis, TN 38105, United States
Eur J Cancer 44:983-91. 2008..Patients are at risk of second malignancies (SM) after treatment for Ewing sarcoma family of tumours (ESFT)...
Effect of fractionated ifosfamide on the pharmacokinetics of irinotecan in pediatric patients with osteosarcomaKristine R Crews
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
J Pediatr Hematol Oncol 26:764-7. 2004..The reduced area under the curve to the active metabolite SN-38 during ifosfamide therapy predicts a compromised efficacy of irinotecan in this combination...
Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleationMatthew W Wilson
Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Invest Ophthalmol Vis Sci 47:1269-73. 2006..To compare the expression of multidrug-resistant proteins in retinoblastoma tumors among eyes treated with primary enucleation...
A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumorsFredric A Hoffer
Department of Radiological Sciences, St Jude Children s Research Hospital, and Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA
Cancer 115:1328-37. 2009..This prospective study was designed to be the first to evaluate the toxicity of radiofrequency ablation (RFA) in patients with recurrent pediatric solid tumors...
Comparison of two methods for carboplatin dosing in children with retinoblastomaSteven Allen
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Pediatr Blood Cancer 55:47-54. 2010..Carboplatin is the most effective drug in retinoblastoma but systemic clearance is variable in young patients. While most regimens use a flat dose, individualized targeting may provide a more adjusted systemic exposure...
UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecanClinton F Stewart
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 25:2594-600. 2007....
Local control in childhood extremity sarcomas: salvaging limbs and sparing functionBhaskar N Rao
Department of Surgery, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA
Med Pediatr Oncol 41:584-7. 2003
Infections in children and young adults with bone malignancies undergoing limb-sparing surgeryAditya H Gaur
Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, USA
Cancer 104:602-10. 2005..The identification of risk factors for ODI may allow modifications of therapy that reduce the incidence and severity of infection, but prevention of all ODIs will require novel strategies...
Childhood hemangiopericytoma: review of St Jude Children's Research HospitalIsrael Fernandez-Pineda
Department of Surgery, St Jude Children s Research Hospital, Memphis, TN 38105 3678, USA
J Pediatr Hematol Oncol 33:356-9. 2011..Intracranial HPC represents a special subtype with a high proclivity toward recurrence and metastasis...
Development of retinoblastoma programs in Central AmericaJudith A Wilimas
International Outreach Program and Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pediatr Blood Cancer 53:42-6. 2009..Jude Children's Research Hospital, and the University of Tennessee Hamilton Eye Institute...
Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastomaMatthew W Wilson
Hamilton Eye Institute, Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
Ophthalmology 116:1558-63. 2009..To correlate the histologic and magnetic resonance imaging results of the optic nerve in eyes primarily enucleated for retinoblastoma...
Ewing sarcoma-family tumors that arise after treatment of primary childhood cancerSheri L Spunt
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Cancer 107:201-6. 2006..ESFT arising as a second cancer was reviewed and characterized at our childhood cancer center...
Neuronal differentiation and synaptogenesis in retinoblastomaDianna A Johnson
Department of Ophthalmology, College of Medicine, University of Tennessee Health Sciences Center, Memphis, USA
Cancer Res 67:2701-11. 2007..Instead, rosette formation reflects extensive cell-cell contacts between retinoblastoma cells in both early-stage (differentiated) and late-stage (dedifferentiated) tumors...
Inactivation of the p53 pathway in retinoblastomaNikia A Laurie
Department of Developmental Neurobiology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Nature 444:61-6. 2006..In addition, they support the idea that MDMX is a specific chemotherapeutic target for treating retinoblastoma...
Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinomaAlina Nico West
Departments of Interdisciplinary Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 338105, USA
Cancer Res 66:5056-62. 2006..Therefore, not all hotspot mutants are functionally equivalent and the biochemical nature of the mutant may significantly influence clinical outcome. The implications of these results for genetic counseling are discussed...
Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinomaDaniel Ka Leung Cheuk
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Cancer 117:197-206. 2011..The authors studied the survival and long-term morbidities of children with nasopharyngeal carcinoma (NPC)...
Extranodal Rosai-Dorfman disease in childrenCarlos Rodriguez-Galindo
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
J Pediatr Hematol Oncol 26:19-24. 2004..The authors describe three patients with RDD who had exclusive extranodal disease in the head and neck area, in whom the clinical presentation mimicked other more common conditions...
Orbital involvement in langerhans cell histiocytosisHouman Vosoghi
Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA
Ophthal Plast Reconstr Surg 25:430-3. 2009..The authors studied a series of patients with Langerhans cell histiocytosis in an attempt to better define the incidence and significance of orbital involvement within the vast spectrum of the disease...
Natural history of moderate aplastic anemia in childrenScott C Howard
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Pediatr Blood Cancer 43:545-51. 2004..We evaluated the rate of progression to SAA...
Use of preclinical models to improve treatment of retinoblastomaMichael A Dyer
Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
PLoS Med 2:e332. 2005
Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancerPamela S Hinds
Division of Nursing Research, St Jude Children s Research Hospital, Memphis, TN, USA
Oncol Nurs Forum 34:393-402. 2007....
PET-CT in pediatric Langerhans cell histiocytosisSue C Kaste
Division of Diagnostic Imaging, Department of Radiological Sciences, St Jude Children s Research Hospital, 332 N Lauderdale, Memphis, TN 38105 2794, USA
Pediatr Radiol 37:615-22. 2007..We conclude that PET-CT information is clinically useful to evaluate disease activity and response to therapy and provides information that cannot be obtained from technetium 99m methylene diphosphonate bone scans or radiographs...
Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plansAlberto S Pappo
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 28:5011-6. 2010..Furthermore, our initial experience has demonstrated to us the potential power of expanded cooperation and collaboration at a global level...
Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in JordanIbrahim Qaddoumi
Department of Pediatric Oncology, King Hussein Cancer Centre KHCC, Amman, Jordan
Pediatr Blood Cancer 51:241-4. 2008..This study evaluated the outcome of retinoblastoma patients, when employing a telemedicine-based twinning program in Jordan...
Bronchioloalveolar carcinoma as a second malignancy in osteosarcoma survivorsJeffrey Lebensburger
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pediatr Blood Cancer 53:499-501. 2009..BAC may present as a solitary pulmonary nodule indistinguishable from a metastatic lesion and should be included in the differential diagnosis of pulmonary nodules in survivors of pediatric cancer...
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinomaGavin C Mackie
Department of Radiological Sciences, St. Jude Children's Research Hospital, 332 North Lauderdale, Mail Stop 752, Memphis, Tennessee 38105-2794, USA
J Clin Endocrinol Metab 91:2665-71. 2006..CONCLUSIONS: Most adrenocortical carcinomas accumulate and retain FDG and thus can be visualized by PET. However, false-negative findings are possible, especially with very small lesions...
Primary malignant peripheral nerve sheath tumor of the lung in a young child without neurofibromatosis type 1Samar A Muwakkit
Children s Cancer Center of Lebanon, American University of Beirut, Beirut, Lebanon, and Department of Hematology and Oncology, St Jude Children s Research Hospital, Memphis, TN, USA
Pediatr Blood Cancer 47:636-8. 2006..MPNST of the lung has similar clinical and radiologic characteristics as pleuropulmonary blastoma. We suggest to include MPNST of the lung in the differential diagnosis of intrapulmonary masses in children...
Retinoblastoma in a patient with an X;13 translocation and facial abnormalities consistent with 13q-syndromeStephen J Laquis
Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
Am J Ophthalmol 133:285-7. 2002..RESULTS: By clinical examination, retinoblastoma was diagnosed in the right eye. CONCLUSION: Chromosomal abnormalities on the long arm of chromosome 13 predispose to retinoblastoma formation and characteristic facial features...
Sister Mary Joseph's nodule as presenting sign of a desmoplastic small round cell tumorLeslie Doros
Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA
Pediatr Blood Cancer 50:388-90. 2008..The diagnosis of an intra-abdominal malignancy, most commonly a DSRCT, should be considered in the presence of an umbilical mass in a child...
Gene expression profiling of childhood adrenocortical tumorsAlina Nico West
Interdisciplinary Science Program, University of Tennessee Health Science Center, Department of Biostatistics, St Jude Children s Research Hospital, Memphis 38105, USA
Cancer Res 67:600-8. 2007..Our findings lay the groundwork for establishing gene expression profiles that may aid in the diagnosis and prognosis of pediatric ACT, and in the identification of signaling pathways that contribute to this disease...
Pyogenic hepatic abscess after percutaneous liver biopsy in a patient with sickle cell diseaseMarta B Garcia-Arias
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA
J Pediatr Hematol Oncol 27:103-5. 2005..The presence of a hepatic abscess should be considered in the differential diagnosis of atypical abdominal pain in patients with SCD...
Heme oxygenase-1 messenger RNA expression is induced in peripheral blood mononuclear cells of pediatric cancer patients with systemic inflammatory response syndromeJeffrey E Schmidt
Division of Critical Care Medicine, Department of Developmental Neurobiology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, TN, USA
Pediatr Crit Care Med 5:554-60. 2004..These findings support a role for heme oxygenase-1 in the physiologic response to inflammatory stress...
c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XLKirsteen H Maclean
Department of Biochemistry, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Mol Cell Biol 23:7256-70. 2003..Therefore, MYC may sensitize tumor cells to DNA damage by suppressing Bcl-X...
Incidence of anemia in children with solid tumors or Hodgkin diseaseMarilyn J Hockenberry
Texas Children s Cancer Center, Texas Children s Hospital, Houston 77030, USA
J Pediatr Hematol Oncol 24:35-7. 2002..The long-term complications of anemia in children with cancer are unknown. Further investigation of the clinical significance of anemia, including its impact on quality of life, is warranted...
Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, BrazilMara A D Pianovski
Department of Pediatric, Hematology and Pediatric Oncology Division, , Brazil
Pediatr Blood Cancer 47:56-60. 2006..In addition, our data suggest that the incidence of ACT in this region is about 12-18 times the incidence reported in the United States and Europe...
The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvementCélia Beatriz Gianotti Antoneli
Pediatrics Department, Centro de Tratamento e Pesquisa Hospital do Cancer A C Camargo, Sao Paulo, Brazil
J Pediatr Hematol Oncol 29:700-4. 2007..2%, respectively, for patients treated during periods I and II (P=0.061). The addition of ifosfamide/etoposide to chemotherapy with cisplatin/teniposide improves survival in these patients, but further studies are still necessary...
Impact of an education program on late diagnosis of retinoblastoma in HondurasChristopher Leander
Weill Cornell Medical College, New York, New York, USA
Pediatr Blood Cancer 49:817-9. 2007..Early diagnosis is necessary to improve the survival of children with retinoblastoma in these countries...
Reducing irinotecan-associated diarrhea in childrenLars M Wagner
Division of Pediatric Hematology Oncology, Cincinnati Children s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Pediatr Blood Cancer 50:201-7. 2008..This approach is feasible in children and allows for tolerance of higher doses of protracted irinotecan...
Intra-arterial cisplatin in osteosarcoma: same question, different answerBhaskar N Rao
Ann Surg Oncol 10:481-3. 2003
Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemiaMichael R Jeng
Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA
Pediatr Blood Cancer 45:170-5. 2005..The addition of G-CSF to IS shortens the time to neutrophil count recovery, but may not improve overall survival. Because GM-CSF acts differently than G-CSF, its use in combination with IS may be different...
Osteosarcoma of the pelvis in children and young adults: the St. Jude Children's Research Hospital experienceRaya Saab
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA
Cancer 103:1468-74. 2005..CONCLUSIONS: Pelvic osteosarcomas often were large and unresectable. A high propensity for metastasis contributed to the poor outcome of patients with pelvic osteosarcoma. New therapeutic approaches are needed...
Corneal juvenile xanthogranuloma in a 4-month-old childEmily D Ashmore
Department of Ophthalmology, University of Tennessee Health Science Center, 956 Court Ave, D-228, Memphis, TN 38163, USA
Arch Ophthalmol 121:117-8. 2003
Germline TP53 R337H mutation is not sufficient to establish Li-Fraumeni or Li-Fraumeni-like syndromeRaul C Ribeiro
Cancer Lett 247:353-5; author reply 356-8. 2007
